Discussion of MRCTs an “urgent imperative”


The 7th Asian New Drug Development Conference, to be held in Tokyo, Japan from April 15 to 16, will provide a forum for discussion about how MRCT data should be used in new drug applications. Program Chair Dr. Kihito Takahashi, M.D., Ph.D., vice president, Japan Development and Medical Affairs Division, GlaxoSmithKline K.K., said: “As understanding has deepened through experience with these trials, it is an urgent imperative for industry, government and academia to come together to discuss and resolve outstanding issues, and make improvements in collaboration internationally to activate new drug development in Asia.” Find out more.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President, Science and Regulatory Affairs
American Beverage Association
Washington, DC
Senior Manager of Medical Management
Network Health
Medford, MA
Columbus, OH
Manager, Medical Management
Network Health
Medford, MA
Medical Director - Cataract
Santa Ana, CA